Home Stock

Stock Research: Profound Medical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Profound Medical

TOR:PRN CA74319B5027
75
  • Value
    22
  • Growth
    95
  • Safety
    Safety
    88
  • Combined
    92
  • Sentiment
    35
  • 360° View
    360° View
    75
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Profound Medical Corp. develops and markets customizable, incision-free therapies for diseased tissue ablation. It operates in the medical device industry, commercializing TULSA-PRO for prostate disease and Sonalleve for uterine fibroids and palliative pain. In the last fiscal year, the company had a market cap of $172 million, profits of $7 million, and revenue of $11 million.

more

ANALYSIS: With an Obermatt 360° View of 75 (better than 75% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Profound Medical are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Profound Medical. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 88 which means that the company has a financing structure that is safer than 88% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 22 which means that the share price of Profound Medical is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 78% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 35, which means that professional investors are more pessimistic about the stock than for 65% of alternative investment opportunities. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Revenue Growth
Country Canada
Industry Health Care Equipment
Size Small
Website profoundmedical.com
Index
NASDAQ
Profound Medical stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 7-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
22 27 8 57
Growth
95 35 47 17
Safety
Safety
88 30 42 91
Sentiment
35 50 78 28
360° View
360° View
75 14 26 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
75 100 93 73
Opinions Change
50 28 50 50
Pro Holdings
n/a 8 49 14
Market Pulse
21 71 61 37
Sentiment
35 50 78 28
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
22 27 8 57
Growth
95 35 47 17
Safety Safety
88 30 42 91
Combined
92 1 10 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
21 16 3 36
Price vs. Earnings (P/E)
67 23 23 12
Price vs. Book (P/B)
25 45 27 96
Dividend Yield
1 1 1 1
Value
22 27 8 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
98 100 98 99
Profit Growth
25 17 50 29
Capital Growth
96 14 3 7
Stock Returns
75 41 49 9
Growth
95 35 47 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
85 69 66 83
Refinancing
48 51 65 83
Liquidity
67 4 11 9
Safety Safety
88 30 42 91

Similar Stocks

Discover high‑ranked alternatives to Profound Medical and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Fairfax India Holdings

TOR:FIH.U
Country: Canada
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Linamar

TOR:LNR
Country: Canada
Industry: Auto Parts & Equipment
Size: Large
Full Stock Analysis

Equinox Gold

ASQ:EQX
Country: Canada
Industry: Gold Production
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews